News & Media

Take a look inside our world

Press Releases

Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims

Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims

Teva Presents New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at 2022 American Psychiatric As...

Teva Presents New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at 2022 American Psychiatric Associa

United Kingdom first to grant licence for Teva’s ophthalmology biosimilar Ongavia (ranibizumab)▼

United Kingdom first to grant licence for Teva’s ophthalmology biosimilar Ongavia (ranibizumab)▼

Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Associatio...

Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Ann

Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalat...

Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation P

Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potentia...

Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of

Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust...

Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targ

Teva Reports First Quarter 2022 Financial Results

Teva Reports First Quarter 2022 Financial Results

Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM

Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM

Feature stories

How Teva is Making Innovative Use of AI and Advanced Analytics in the Pharma and Health Sector

How Teva is Making Innovative Use of AI and Advanced Analytics in the Pharma and Health Sector

Teva goes to University: Collaborating with Academia to Improve the Lives of Patients

Teva goes to University: Collaborating with Academia to Improve the Lives of Patients

All the Latest on LinkedIn

Consider digitalization in pharmacovigilance - what if it meant globalization that delivers greater patient-centricity, while also helping to reduce costs, improve compliance and increase employee engagement? Teva’s Dr. Sebastian Horn, VP, Head of Global Patient Safety & Pharmacovigilance, provides...

Read more

Boglárka Szabóné Szikszai makes sure to teach her two teenage daughters how to be self-assured and resilient, work hard and never give up. After all, these characteristics played a big part of her success, which saw her progress throughout her two-decade career at Teva. These days, she leads a te...

Read more

Biosimilar medicines are potentially less expensive than original biologics, whilst having the same effectiveness. Meet Cory Wohlbach, who is responsible for steering Teva’s new biosimilar products through the regulatory approval process. Here he explains how biosimilars have the potential to reduc...

Read more

Meet Samuel Frere and Elena Lapkina Gendler, scientists who work in the non-clinical (early stage) research lab in Netanya, Israel. Their work allows their group to test the effect of Teva drugs on gene expression and on cellular function. While they took very different paths to get there, both...

Read more

At Teva, we know that providing medicines is an important job—and conducting business ethically and responsibly is non-negotiable. In 2021, we trained 20,000+ employees on ethics (99.6% of those assigned), published three new position statements on patient safety, responsible supply chain and risk m...

Read more

When most of us think about becoming parents, we picture sunlit afternoons chasing our toddlers through the park, birthday parties, vacations, and school sports days. We often don't envision how difficult parenting can be when coping with the pain, fatigue, hospital appointments, and diagnoses that...

Read more

What does family mean to you? For many of us, no words could encompass the emotional, developmental, and spiritual importance of family life. Family is about love. It's about understanding, hope, comfort, advice, and encouragement. We treasure the people on our home team through the good times and t...

Read more

Yesterday we had the pleasure of hosting the Teva satellite event "Challenges & Opportunities in CNS Drug Discovery" at the 2022 Biomed conference. Thank you to all the participants, the room was full of unique energy. We learned about multidisciplinary efforts to advance this complex field such as...

Read more

Further unlocking the value of critical medicines with biosimilars is an important frontier in drug development. It offers patients safe and effective treatment options through more affordable alternatives to branded biological products that have lost their exclusivity rights.  Accelerating patient...

Read more

Supporting patient lives and healthcare systems: we’re using Artificial Intelligence (AI) and advanced analytics to improve the drug development process and help provide medicines for patients with various conditions such as schizophrenia, depression, Parkinson’s and Chronic Obstructive Pulmonary Di...

Read more

Contacts for Media Inquiries

Kelley Dougherty

North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Leslie McGibbon

Europe

Leslie.Mcgibbon@Tevaeu.com


Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Teva Social Media Guidelines

Connect with us